Dianthus Therapeutics (DNTH) Amortizatization of Intangibles (2022 - 2025)

Dianthus Therapeutics' Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $2.3 million for Q3 2025.

• On a quarterly basis, Amortizatization of Intangibles fell 1.28% year-over-year to $2.3 million in Q3 2025; TTM through Sep 2025 was $8.0 million, a 111.27% increase from a year earlier, with the FY2024 full-year figure at $6.0 million, up 322.91% from the prior year.
• Amortizatization of Intangibles grew to $2.3 million in Q3 2025 per DNTH's latest filing, from $1.1 million in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $2.7 million in Q4 2024 and bottomed at $208000.0 in Q2 2023.
• The 4-year median for Amortizatization of Intangibles is $522500.0 (2023), against an average of $1.1 million.
• Across the five-year window, Amortizatization of Intangibles surged 609.39% in 2024 and retreated 1.28% in 2025, its largest moves.
• Year by year, Amortizatization of Intangibles stood at $402000.0 in 2022, then jumped by 31.09% to $527000.0 in 2023, then jumped by 419.35% to $2.7 million in 2024, then fell by 15.56% to $2.3 million in 2025.
• Per Business Quant, the three latest DNTH Amortizatization of Intangibles figures stand at $2.3 million (Q3 2025), $1.1 million (Q2 2025), and $1.9 million (Q1 2025).